Cellebrite to Report Second-Quarter 2023 Financial Results on August 8, 2023

PETAH TIKVA, Israel and TYSONS CORNER, Va., July 12, 2023 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced it will report its second-quarter 2023 financial results before market open on Tuesday, August 8, 2023. Later that same morning, Cellebrite will host […]

Read More »

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced a $50 million investment by NVIDIA, which was executed as […]

Read More »

AMFRESH and EQT expect to close the acquisition of IFG by SNFL in the coming weeks, after the approval of the transaction by the European Commission

The positive verdict of the arbitration process initiated by a third party trying to block the deal AMFRESH MADRID, Spain, July 12, 2023 (GLOBE NEWSWIRE) — Following the agreement between International Fruit Genetics LLC (IFG) and Special New Fruit Licensing Limited (SNFL), the consortium led by AMFRESH Group, as well as the Swedish fund EQT […]

Read More »

Webull Launches in the United Kingdom

LONDON, July 12, 2023 (GLOBE NEWSWIRE) — Webull Corporation (“Webull”), the owner of the popular Webull trading platform, today announced the launch of its retail brokerage services in the UK. Through licensed financial services trading firm Webull Securities (UK) Ltd. (“Webull UK”), a subsidiary of Webull, residents of the UK can now trade U.S.-listed equities […]

Read More »